Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19655250 | 0.91 | LIMK1 (0.34) | LIMK1 | |
| SCHEMBL19655419 | 0.91 | PDE10A (0.34) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19655192 | 0.89 | MEN1 (0.34) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19653921 | 0.88 | PDE10A (0.33) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19655183 | 0.87 | LIMK1 (0.34) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19655196 | 0.84 | L3MBTL1 (0.44) | GAAMEN1KMT2AL3MBTL1HSD17B10 | |
| SCHEMBL19655211 | 0.83 | GSR (0.40) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19655200 | 0.83 | MEN1 (0.34) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19655201 | 0.83 | KMT2A (0.40) | GAAMEN1KMT2APDE10AL3MBTL1 | |
| SCHEMBL19655194 | 0.83 | KMT2A (0.41) | GAAMEN1KMT2APDE10AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10840458-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-17 | — | — | US | disclosed |
| US-20170346022-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170346022-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170346022-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PDXK, MT-ND4L, PNPO | GAA 2621/4885MEN1 2827/4885KMT2A 3170/4885 |
| US-10840458-B2 | Organic electroluminescent materials and devices | PDXK, MT-ND4L, PNPO | GAA 2621/4885MEN1 2827/4885KMT2A 3170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.